Caricamento...
PCSK9 Monoclonal Antibodies: An Overview
PCSK9 monoclonal antibodies are novel lipid-lowering therapy that have been extensively studied in patients with hypercholesterolemia either as monotherapy or as an add-on to other LLTs. PCSK9 monoclonal antibodies have significantly reduced the low-density lipoprotein cholesterol (LDL-C) plasma lev...
Salvato in:
| Pubblicato in: | Heart Views |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Wolters Kluwer - Medknow
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7507904/ https://ncbi.nlm.nih.gov/pubmed/33014302 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/HEARTVIEWS.HEARTVIEWS_20_20 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|